Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Interest & Investment Income came in at $297000.0 in Q1 2026, down 7.76% YoY from $322000.0 in Q1 2025, and down 30.44% on a QoQ basis from $427000.0 in Q4 2025.
Powered by 
Analysis
Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Interest & Investment Income data on file, last reported at $297000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 7.76% year-over-year to $297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 36.36% YoY) and the FY2025 annual result came in at $1.5 million, down 36.54% from the prior year.
- Interest & Investment Income slipped to $297000.0 in Q1 2026, from $427000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $833000.0 in Q2 2024 to a low of $4000.0 in Q1 2022.
- A 5-year average of $304235.3 and a median of $262000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 4725.0% — and 2025, when it plunged 76.95%.
- Tracing ACHV's Interest & Investment Income over 5 years: stood at $118000.0 in 2022, then jumped by 76.27% to $208000.0 in 2023, then jumped by 131.73% to $482000.0 in 2024, then slipped by 11.41% to $427000.0 in 2025, then plunged by 30.44% to $297000.0 in 2026.
- The last three Interest & Investment Income figures came in at $297000.0 (Q1 2026), $427000.0 (Q4 2025), and $554000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | 1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 297,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |